prednisone
Showing 1 - 25 of 945
Hepatocellular Carcinoma Trial (Prednisone)
Not yet recruiting
- Hepatocellular Carcinoma
- Prednisone
- (no location specified)
Jun 2, 2023
In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)
Not yet recruiting
- In-stent Restenosis
- Colchicine
- +4 more
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 15, 2023
Acute Heart Failure Trial (Prednisone)
Not yet recruiting
- Acute Heart Failure
- Prednisone
- (no location specified)
Jun 14, 2023
Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)
Not yet recruiting
- Large B-Cell Lymphoma
- Glofitamab
- +5 more
-
Xi'an, ChinaFirst Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023
Langerhans Cell Histiocytosis of Bone Trial in Shanghai (Prednisone)
Recruiting
- Langerhans Cell Histiocytosis of Bone
- Prednisone
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Oct 15, 2023
Nephrotic Syndrome in Children Trial (Huaiqihuang granule, Prednisone, Levamisole )
Not yet recruiting
- Nephrotic Syndrome in Children
- Huaiqihuang granule
- +4 more
- (no location specified)
Mar 6, 2023
Facial Swelling, Tooth Position Anomalies, Tooth, Impacted Trial in Catanzaro (Prednisone, Placebo)
Completed
- Facial Swelling
- +4 more
- Prednisone
- Placebo
-
Catanzaro, CZ, ItalyMagna Graecia University of Catanzaro
Apr 23, 2023
Healthy, Atopic Dermatitis Trial in Daytona Beach (LY3872386, Prednisone, Placebo)
Not yet recruiting
- Healthy
- Atopic Dermatitis
- LY3872386
- +2 more
-
Daytona Beach, FloridaFortrea Clinical Research Unit
Nov 1, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Not yet recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +12 more
- Biopsy
- +8 more
- (no location specified)
Jun 8, 2023
Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement
Recruiting
- Lymphoma
- +4 more
- Vysis LSI MYC Break Apart Rearrangement Probe Kit
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Abiraterone Acetate/Niraparib
- +5 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 9, 2023
Multiple Myeloma Trial in Saint Louis (Isatuximab, Bendamustine, Prednisone)
Recruiting
- Multiple Myeloma
- Isatuximab
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Sep 21, 2022
Vasectomy Reversal Trial in Orem (Prednisone)
Recruiting
- Vasectomy Reversal
- Prednisone
-
Orem, UtahCure PD
Jul 19, 2022
Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Advanced Cancer
- Cemiplimab
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Gout, Chronic Kidney Disease, Renal Transplantation Trial in Paris (Anakinra 100Mg/0.67Ml Inj Syringe, Prednisone, Placebo of
Recruiting
- Gout
- +2 more
- Anakinra 100Mg/0.67Ml Inj Syringe
- +3 more
-
Paris, Ile-De-France, FranceRhumathology department
Aug 22, 2022
Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)
Recruiting
- Prostate Cancer Metastatic
- Prostate Cancer
- Abiraterone Acetate
- Prednisone
-
Houston, Texas
- +2 more
Oct 7, 2022
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute
Recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Dasatinib
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 16, 2022
Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone
Active, not recruiting
- Metastatic Prostate Carcinoma
- +5 more
- Abiraterone Acetate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 26, 2022
Immune Thrombocytopenia Trial in Beijing (Prednisone, Recombinant Human TPO)
Recruiting
- Immune Thrombocytopenia
- Prednisone
- Recombinant Human TPO
-
Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Apr 17, 2022
Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)
Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)
Recruiting
- Lymphoma
- +3 more
- Venetoclax
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the NCI (obinutuzumab, prednisone, Revlimid)
Recruiting
- Lymphoma
- +3 more
- obinutuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)
Not yet recruiting
- Inflammatory Arthritis
- Immune-related Adverse Event
- Adalimumab
- Prednisone
- (no location specified)
Sep 13, 2023